4:27 pm Chelsea Therapeutics reports EPS in-line; co continues to pursue a dual path of actively assessing the Company’s strategic alternatives and preparing for the commercial launch of NORTHERA – HedgeChatter

4:27 pm Chelsea Therapeutics reports EPS in-line; co continues to pursue a dual path of actively assessing the Company’s strategic alternatives and preparing for the commercial launch of NORTHERA

12 Mar

4:27 pm Chelsea Therapeutics reports EPS in-line; co continues to pursue a dual path of actively assessing the Company’s strategic alternatives and preparing for the commercial launch of NORTHERA

Bystocknews CHTP, stock Comments Off

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Chelsea is hiring next, click here to view

Author